Results 1 to 10 of about 49,884 (142)
Fcγ receptor expression on monocytes and association with etanercept efficacy in rheumatoid arthritis: a prospective cohort study [PDF]
Frontiers in PharmacologyBackgroundTo investigate whether Fcγ receptors (FcγRs) expression on peripheral blood monocytes predicts clinical response to etanercept in rheumatoid arthritis (RA).MethodsIn this prospective cohort study, FcγRs expression on peripheral blood monocyte ...
Tongxin Wang +8 more
doaj +2 more sources
RMD Open, 2021 Objectives We examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with methotrexate (MTX) monotherapy ...
Vibeke Strand +5 more
doaj +1 more source
Etanercept Ameliorates Cardiac Fibrosis in Rats with Diet-Induced Obesity
Pharmaceuticals, 2021 Diet-induced obesity (DIO) is considered the main risk factor for cardiovascular diseases. Increases in the plasma levels of tumor necrosis factor alpha (TNF-α) is associated with DIO.
Chia-Chen Hsu +6 more
doaj +1 more source
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up. [PDF]
PLoS ONE, 2018 OBJECTIVES:To determine the percentage non-adherence to etanercept in patients with rheumatoid arthritis during three years of follow-up. METHODS:During study visits in this prospective cohort study, blood samples were taken to determine serum etanercept
E H Vogelzang +7 more
doaj +1 more source
Rheumatology International, 2014 Etanercept was the first tumour necrosis factor alpha antagonist approved in the USA for the treatment of rheumatoid arthritis, in 1998, and then for other diseases. With the etanercept patent set to expire in the EU in 2015, a number of etanercept copies have reached the production phase and are undergoing clinical trials, with the promise of being ...
Azevedo, Valderilio F. +4 more
openaire +2 more sources
Effect of etanercept on post-traumatic proliferative vitreoretinopathy [PDF]
International Journal of Ophthalmology, 2019 AIM: To evaluate the safety and efficacy of intravitreal etanercept in the inhibiting of proliferative vitreoretinopathy (PVR) in a model of penetrating ocular injury.
Xiao-Feng Chen +3 more
doaj +1 more source
Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress. [PDF]
PLoS ONE, 2014 The protective role of etanercept in myocardial ischemia/reperfusion is not well understood. The aim of this study was to investigate whether etanercept modulates neutrophil accumulation, TNF-α induction and oxidative stress in an ischemia/reperfusion ...
Mei Yang +3 more
doaj +1 more source
Maternal and Fetal-Placental Effects of Etanercept Treatment During Rats’ Pregnancy
Frontiers in Physiology, 2022 Etanercept is a tumor necrosis factor alpha (TNF-α) inhibitor chronically used to treat autoimmune diseases. However, the use of etanercept during pregnancy still needs to be further investigated.
Gabriel Gomes Araujo +7 more
doaj +1 more source
Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain. [PDF]
PLoS ONE, 2013 Tumor necrosis factor-α plays important roles in immune system development, immune response regulation, and T-cell-mediated tissue injury. The present study assessed the net value of anti-tumor necrosis factor-α treatment in terms of functional recovery ...
Katsuyuki Iwatsuki +7 more
doaj +1 more source